Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif-Reference-Cited by-同舟云学术

Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif

Published:2014-03 Issue:13 Volume:289 Page:8839-8851
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jehle Katja,Cato Laura,Neeb Antje,Muhle-Goll Claudia,Jung Nicole,Smith Emmanuel W.,Buzon Victor,Carbó Laia R.,Estébanez-Perpiñá Eva,Schmitz Katja,Fruk Ljiljana,Luy Burkhard,Chen Yu,Cox Marc B.,Bräse Stefan,Brown Myles,Cato Andrew C.B.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference71 articles.

1. The androgen receptor in health and disease;Matsumoto;Annu. Rev. Physiol.,2013

2. Androgen receptor (AR) aberrations in castration-resistant prostate cancer;Waltering;Mol. Cell Endocrinol.,2012

3. Chromatin binding by the androgen receptor in prostate cancer;Itkonen;Mol. Cell Endocrinol.,2012

4. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling;Claessens;Nucl. Recept. Signal.,2008

5. A signature motif in transcriptional co-activators mediates binding to nuclear receptors;Heery;Nature.,1997

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPAR gamma and PGC‐1alpha activators protect against diabetic nephropathy by suppressing the inflammation and NF‐kappaB activation;Nephrology;2024-09-04

2. Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer;Molecular Cancer Therapeutics;2024-02-27

3. Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer;Laboratory Investigation;2023-11

4. Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer;SLAS Discovery;2023-10

5. The multivalency of the glucocorticoid receptor ligand-binding domain explains its manifold physiological activities;Nucleic Acids Research;2022-12-05